Crown Aesthetics, a division of Crown Laboratories, Inc., has announced that the U.S. Food and Drug Administration (FDA) has cleared SkinPen Precision for the treatment of wrinkles on the neck.
The administration's decision came following a recent single-center clinical study, which demonstrated clinical improvement of dermal lines on the neck and high patient satisfaction at one and three months post-treatment. From this study, it was found that 94% of patients noticed an improvement in how their wrinkles looked in their treated area one month post-procedure, and 88% of patients were satisfied with their SkinPen Precision treatment one month post-procedure.
Read more at PR Newswire >>